[HTML][HTML] Gypenoside protects against myocardial ischemia-reperfusion injury by inhibiting cardiomyocytes apoptosis via inhibition of CHOP pathway and activation of …
H Yu, H Zhang, W Zhao, L Guo, X Li, Y Li… - Cellular Physiology and …, 2016 - karger.com
Background/Aims: Ischemia-reperfusion (I/R) injury is believed to be the major cause for
detriments in coronary heart diseases, but few effective therapies for prevention or treatment …
detriments in coronary heart diseases, but few effective therapies for prevention or treatment …
Gypenoside Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting Cardiomyocytes Apoptosis via Inhibition of CHOP Pathway and Activation of PI3K …
H Yu, H Zhang, W Zhao, L Guo, X Li, Y Li… - Cellular Physiology and …, 2016 - go.gale.com
Background/Aims: Ischemia-reperfusion (I/R) injury is believed to be the major cause for
detriments in coronary heart diseases, but few effective therapies for prevention or treatment …
detriments in coronary heart diseases, but few effective therapies for prevention or treatment …
Gypenoside Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting Cardiomyocytes Apoptosis via Inhibition of CHOP Pathway and Activation of PI3K …
H Yu, H Zhang, W Zhao, L Guo, X Li, Y Li… - Cellular Physiology and …, 2016 - cir.nii.ac.jp
抄録< jats: p> Background/Aims: Ischemia-reperfusion (I/R) injury is believed to be the major
cause for detriments in coronary heart diseases, but few effective therapies for prevention or …
cause for detriments in coronary heart diseases, but few effective therapies for prevention or …
Gypenoside Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting Cardiomyocytes Apoptosis via Inhibition of CHOP Pathway and Activation of PI3K …
H Yu, H Zhang, W Zhao, L Guo, X Li, Y Li… - Cellular Physiology …, 2016 - europepmc.org
Methods effect GP on the cardiac structure of I/R injured rats was assessed by H&E and TTC
staining. Then the influence of GP on the cardiac function of rat model was determined by …
staining. Then the influence of GP on the cardiac function of rat model was determined by …
Gypenoside Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting Cardiomyocytes Apoptosis via Inhibition of CHOP Pathway and Activation of PI3K …
H Yu, H Zhang, W Zhao, L Guo, X Li… - Cellular Physiology …, 2016 - search.ebscohost.com
Abstract Background/Aims: Ischemia-reperfusion (I/R) injury is believed to be the major
cause for detriments in coronary heart diseases, but few effective therapies for prevention or …
cause for detriments in coronary heart diseases, but few effective therapies for prevention or …
Gypenoside Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting Cardiomyocytes Apoptosis via Inhibition of CHOP Pathway and Activation of PI3K …
H Yu, H Zhang, W Zhao, L Guo, X Li… - Cellular physiology …, 2016 - pubmed.ncbi.nlm.nih.gov
Background/aims Ischemia-reperfusion (I/R) injury is believed to be the major cause for
detriments in coronary heart diseases, but few effective therapies for prevention or treatment …
detriments in coronary heart diseases, but few effective therapies for prevention or treatment …
Gypenoside Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting Cardiomyocytes Apoptosis via Inhibition of CHOP Pathway and Activation of PI3K …
H Yu, H Zhang, W Zhao, L Guo, X Li, Y Li… - Cellular Physiology and …, 2016 - karger.com
Abstract Background/Aims: Ischemia-reperfusion (I/R) injury is believed to be the major
cause for detriments in coronary heart diseases, but few effective therapies for prevention or …
cause for detriments in coronary heart diseases, but few effective therapies for prevention or …
Gypenoside Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting Cardiomyocytes Apoptosis via Inhibition of CHOP Pathway and Activation of PI3K …
H Yu, H Zhang, W Zhao, L Guo, X Li, Y Li, X Zhang… - 2016 - agris.fao.org
Background/Aims: Ischemia-reperfusion (I/R) injury is believed to be the major cause for
detriments in coronary heart diseases, but few effective therapies for prevention or treatment …
detriments in coronary heart diseases, but few effective therapies for prevention or treatment …
[PDF][PDF] Gypenoside Protects against Myocardial Ischemia–Reperfusion Injury by Inhibiting Cardiomyocytes Apoptosis via Inhibition of CHOP Pathway and Activation of …
HYHZW Zhao, LGXLY Li, XZY Sun - Cell Physiol Biochem, 2016 - cyberleninka.org
Abstract Background/Aims: Ischemia-reperfusion (I/R) injury is believed to be the major
cause for detriments in coronary heart diseases, but few effective therapies for prevention or …
cause for detriments in coronary heart diseases, but few effective therapies for prevention or …
[PDF][PDF] Gypenoside Protects against Myocardial Ischemia–Reperfusion Injury by Inhibiting Cardiomyocytes Apoptosis via Inhibition of CHOP Pathway and Activation of …
HYHZW Zhao, LGXLY Li, XZY Sun - Cell Physiol Biochem, 2016 - scholar.archive.org
Abstract Background/Aims: Ischemia-reperfusion (I/R) injury is believed to be the major
cause for detriments in coronary heart diseases, but few effective therapies for prevention or …
cause for detriments in coronary heart diseases, but few effective therapies for prevention or …